Preserving pancreas function can make glucose control easier and reduce the need to use injected insulin

Study in progress - not recruiting
HREC ethics approval number 2022.079
This research study is no longer accepting participants. The following details are for information only.

About the study

When Type 1 diabetes is first diagnosed, the pancreas is still able to make small amounts of insulin, which helps control glucose levels. Preserving pancreas function can make glucose control easier and reduce the need to use injected insulin. This study investigates whether the combination of two immune therapies called abatacept and nasal insulin can preserve pancreas function in recently diagnosed type 1 diabetes.

Contact us to find out more about this research study, quoting reference number 2022.079
Person handling test tubes for research

Ethics

All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.

This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.

Related services